Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001140361-24-014680

Options or other derivatives

  • Director acquired 1,866 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nussbaum Rodney L · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,866 1,866 D
Loading xslF345X05/form4.xml…